Healthy volunteers test new drug delivery methods for ziltivekimab
NCT ID NCT05721989
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 19 times
Summary
This study looked at how the body absorbs and processes different forms of the experimental drug ziltivekimab. It involved 267 healthy adults who received a single injection under the skin, either with a syringe or a pen-injector. The goal was to compare how well each method works and to check the drug's safety. This is an early-stage study, so the drug is not yet approved for use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON - location Groningen
Groningen, 9728 NZ, Netherlands
-
ICON Budapest Phase I Unit
Budapest, 1077, Hungary
Conditions
Explore the condition pages connected to this study.